Lexicon Pharmaceuticals Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | 2.1 | 3.4 | 2.5 | 5.5 | – | – | – | 17.4 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 10.0 | 17.2 | 16.8 | 21.4 | 16.2 | 11.6 | 9.3 | 12.8 | 14.4 | 11.1 | 12.7 | 15.6 | 1.1 | 1.4 | 0.7 | 0.7 | 5.1 | 17.3 | 52.8 | 93.7 | 1,449.1 | 1,948.7 | 1,016.9 | 2,608.0 | 3,358.2 | 2,579.7 | 3,600.3 | 1,154.4 | 507.4 | 304.9 | 254.8 | 145.1 | 110.6 | 8.6 | 5.3 | 5.9 | 7.2 | 8.8 | 9.2 | 25.3 | |
| 10.2 | 9.1 | 11.1 | 16.3 | 16.6 | 20.1 | 34.7 | – | – | – | – | – | 2.1 | 3.8 | 3.9 | – | 1.9 | 2.7 | 5.5 | 4.8 | 5.1 | 5.1 | 3.4 | 4.0 | 2.9 | 3.1 | 5.2 | 2.5 | 1.9 | 3.9 | 2.0 | 2.2 | 3.2 | 1.8 | 1.4 | 2.7 | 4.2 | 4.1 | 3.2 | 6.0 | |
| 8.3 | 13.9 | 14.9 | 22.1 | 16.2 | 10.9 | 11.5 | 15.0 | 16.7 | 12.2 | 16.9 | 18.9 | 1.3 | 2.0 | 1.3 | 1.2 | 4.1 | 12.6 | 47.5 | 82.8 | 1,284.8 | 1,737.3 | 903.0 | 2,635.2 | 3,409.0 | 2,605.1 | 3,791.8 | 1,149.0 | 657.0 | 369.9 | 256.9 | 163.0 | 123.4 | 9.7 | 6.6 | 6.5 | 7.3 | 9.2 | 9.4 | 25.6 | |
| – | – | – | – | – | – | – | – | – | – | – | – | 2.3 | 4.4 | 3.9 | 6.5 | – | – | – | 13.6 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 13.6 | – | – | – | – | – | – | – | – | – | – | – | 3.2 | 3.9 | 1.8 | 2.2 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 7.4% | -12.2% | -14.6% | -11.6% | -15.5% | -17.8% | -16.2% | -13.2% | -13.7% | -21.3% | -21.5% | -15.2% | 31.7% | 25.5% | 55.1% | 45.8% | -80.9% | -34.4% | -17.3% | -18.5% | -14.2% | -15.2% | -27.6% | -31.0% | -21.5% | -25.1% | -21.7% | -23.9% | -50.0% | -44.2% | -31.5% | -37.1% | -36.0% | -67.4% | -101.0% | -29.7% | -14.3% | -15.6% | -6.1% | -7.6% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 10.3% | -113.8% | -58.6% | -15.5% | 48.0% | 97.9% | 97.7% | 97.5% | 96.9% | 96.0% | 94.6% | 93.0% | 99.1% | 99.0% | 99.0% | 99.2% | 91.7% | 87.8% | 6.6% | -245.2% | -4,839.5% | -13,109.4% | -8,622.1% | -15,135.8% | -13,185.6% | -52.5% | 18.3% | 72.8% | 77.8% | -1,132.1% | -550.0% | -316.9% | -191.5% | 15.2% | 16.1% | 55.1% | 63.1% | 98.9% | 99.1% | 98.9% | |
| -9.3% | -164.6% | -163.5% | -175.9% | -170.8% | -151.3% | -135.9% | -130.1% | -155.0% | -165.1% | -177.6% | -166.8% | 53.4% | 43.9% | 30.1% | 15.7% | -269.2% | -199.2% | -38.7% | 569.8% | -14,330.8% | -29,224.8% | -29,101.0% | -87,778.9% | -76,649.6% | -72,489.2% | -86,128.6% | -31,557.6% | -29,245.0% | -14,253.1% | -8,045.9% | -5,412.1% | -4,037.4% | -634.2% | -568.6% | -202.6% | -94.4% | -98.2% | -34.8% | -131.4% | |
| -11.9% | -169.7% | -158.7% | -170.6% | -165.7% | -142.9% | -140.1% | -137.3% | -168.2% | -192.5% | -214.9% | -208.1% | 49.8% | 40.4% | 26.6% | 12.3% | -320.4% | -244.1% | -80.6% | 536.8% | -14,004.6% | -29,449.0% | -29,310.4% | -88,803.7% | -77,648.8% | -73,341.0% | -87,620.6% | -32,039.0% | -29,728.2% | -14,698.7% | -8,376.5% | -5,550.9% | -4,138.3% | -644.8% | -568.0% | -206.4% | -96.8% | -101.1% | -37.5% | -147.4% | |
| 74.0% | -211.0% | -244.2% | -249.1% | -250.0% | -205.5% | -151.0% | -168.9% | -196.9% | -236.5% | -272.0% | -238.0% | 33.6% | 35.3% | 36.6% | 30.6% | -409.4% | -596.2% | -912.4% | -1,730.0% | -20,637.7% | -29,610.1% | -28,096.8% | -80,856.0% | -72,170.4% | -64,875.5% | -78,207.1% | -27,542.9% | -25,354.8% | -13,474.4% | -8,032.7% | -5,387.8% | -3,985.4% | -578.5% | -539.7% | -175.7% | -102.4% | -136.2% | -55.7% | -192.2% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -12.0% | -89.9% | -105.1% | -130.2% | -169.8% | -247.7% | -520.1% | – | – | – | – | – | 99.9% | 111.1% | 155.8% | – | -118.9% | -37.5% | -8.5% | 27.8% | -49.5% | -77.3% | -97.4% | -136.7% | -67.4% | -87.0% | -125.4% | -70.1% | -113.2% | -190.2% | -67.0% | -84.2% | -121.2% | -137.3% | -144.1% | -93.2% | -57.1% | -46.8% | -12.9% | -35.0% | |
| -4.3% | -29.7% | -35.7% | -38.1% | -40.4% | -29.6% | -35.2% | -40.8% | -42.8% | -42.6% | -39.0% | -38.2% | 37.0% | 31.2% | 23.0% | 12.2% | -58.2% | -28.7% | -6.7% | 22.2% | -39.3% | -64.1% | -66.3% | -86.2% | -50.6% | -52.5% | -67.8% | -41.3% | -57.1% | -77.2% | -46.4% | -54.1% | -67.4% | -67.2% | -59.6% | -53.5% | -33.3% | -27.2% | -9.7% | -24.4% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -327 | -277 | -169 | 59 | 4.1 | -59 | 212 | 217 | 182 | 69 | 199 | 139 | 75 | 210 | 190 | 159 | -31 | -114 | -85 | -77 | -79 | -63 | -35 | 3.0 | 6.4 | 3.5 | 24 | -2.2 | 79 | 78 | 4.7 | 65 | 67 | 35 | 39 | 36 | 8.5 | 21 | 13 | 12 | |
| – | – | – | – | – | – | – | – | – | – | – | – | 0.4 | 1.4 | 1.8 | 2.8 | – | – | – | -1.8 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 35.8% | 33.1% | 34.0% | 29.2% | 23.8% | 11.9% | 6.8% | -1.5% | -9.5% | -9.3% | -17.7% | -27.8% | 37.0% | 28.0% | 14.8% | -3.3% | 49.0% | 76.7% | 78.9% | 79.9% | 79.3% | 83.0% | 68.1% | 63.1% | 75.1% | 60.3% | 54.1% | 58.8% | 50.5% | 40.6% | 69.2% | 64.3% | 55.6% | 48.9% | 41.3% | 57.4% | 58.4% | 58.1% | 75.5% | 69.8% | |
| 0.4 | 0.4 | 0.7 | 0.8 | 1.1 | 4.8 | 8.9 | – | – | – | – | – | 1.5 | 2.1 | 4.5 | – | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.3 | 0.3 | 0.2 | 0.4 | 0.6 | 0.5 | 0.7 | 1.1 | 0.4 | 0.4 | 0.6 | 0.7 | 0.8 | 0.4 | 0.5 | 0.5 | 0.3 | 0.3 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -0.21 | -1.36 | -1.35 | -1.31 | -1.26 | -1.22 | -1.29 | -1.28 | -1.25 | -1.14 | -0.95 | -0.84 | 1.41 | 1.22 | 0.80 | 0.37 | -0.89 | -0.48 | -0.09 | 0.26 | -0.46 | -0.59 | -0.61 | -0.65 | -0.55 | -0.54 | -0.58 | -0.64 | -0.64 | -0.72 | -0.79 | -0.65 | -0.60 | -0.55 | -0.49 | -0.33 | -0.19 | -0.14 | -0.07 | -0.14 | |
| 1.81 | 0.80 | 0.85 | 0.77 | 0.76 | 0.86 | 0.92 | 0.93 | 0.74 | 0.59 | 0.44 | 0.40 | 2.83 | 3.03 | 3.01 | 2.99 | 0.28 | 0.20 | 0.11 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.09 | 0.09 | 0.16 | 0.20 | 0.14 | 0.17 | 0.09 | |
| 1.78 | 1.51 | 1.29 | 1.01 | 0.74 | 0.49 | 0.25 | -0.05 | -0.28 | -0.25 | -0.43 | -0.61 | 1.41 | 1.10 | 0.51 | -0.10 | 0.75 | 1.28 | 1.06 | 0.95 | 0.94 | 0.76 | 0.62 | 0.47 | 0.82 | 0.62 | 0.47 | 0.91 | 0.57 | 0.38 | 1.18 | 0.77 | 0.49 | 0.40 | 0.34 | 0.36 | 0.33 | 0.30 | 0.51 | 0.40 | |
| 1.34 | -1.69 | -2.08 | -1.92 | -1.90 | -1.76 | -1.39 | -1.58 | -1.47 | -1.40 | -1.20 | -0.96 | 0.95 | 1.07 | 1.10 | 0.92 | -1.13 | -1.17 | -1.02 | -0.85 | -0.68 | -0.59 | -0.58 | -0.59 | -0.52 | -0.48 | -0.52 | -0.55 | -0.55 | -0.66 | -0.76 | -0.63 | -0.58 | -0.50 | -0.47 | -0.28 | -0.20 | -0.19 | -0.10 | -0.18 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.